The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ivanets N.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Tikhonova Iu.G.

Kafedra psikhiatrii i narkologii GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava RF;
Nauchno-obrazovatel'nyĭ klinicheskiĭ tsentr "Psikhicheskoe zdorov'e", Moskva

Kinkul'kina M.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Avdeeva T.I.

Treatment of depression: the current state and perspectives of the development of pharmacological studies

Authors:

Ivanets N.N., Tikhonova Iu.G., Kinkul'kina M.A., Avdeeva T.I.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(10): 108‑116

Read: 2747 times

Download PDF (RU)
Contact the author
Table of contents

TREATMENT OF DEPRESSION: THE CURRENT STATE AND PERSPECTIVES OF THE DEVELOPMENT OF PHARMACOLOGICAL STUDIES
TREATMENT OF DEPRESSION: THE CURRENT STATE AND PERSPECTIVES OF THE DEVELOPMENT OF PHARMACOLOGICAL STUDIES

To cite this article:

Ivanets NN, Tikhonova IuG, Kinkul'kina MA, Avdeeva TI. Treatment of depression: the current state and perspectives of the development of pharmacological studies. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(10):108‑116. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Factors affe­cting the quality of life of patients with neurological mani­festations of post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):44-50
Cere­brolysin in the preventive therapy of deme­ntia in elde­rly patients with mild cognitive impairment: a three-year prospective comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):51-59
EEG features in young female patients with depressive states at different stages of endo­genous mental diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):100-103
The gut microbiota in bipo­lar diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):28-33
Cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):81-90
Quality asse­ssment of health care deli­very to patients with sexually transmitted infe­ctions in dermatovenereological institutions of Moscow acco­rding to medi­cal reco­rds analysis. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):503-509
Psoriasis in pregnant women. Russian Journal of Clinical Dermatology and Vene­reology. 2024;(5):517-524
Impact of various reha­bilitation programs on anxiety and depression after surgery of early-stage cervical cancer. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):40-44
Tube­rculous otitis media in an adolescent. Clinical case. Russian Bulletin of Otorhinolaryngology. 2024;(5):63-66
Pharmacogenetic testing for personalized statin prescription in Moscow. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):49-55
Abstract:

A review of literature over the last two decades is presented. It is emphasized that psyachopharmacotherapy currently remains a main method of treatment of severe and moderate depression. Pharmacogenetic studies are directed mainly towards the identification of probable targets of antidepressant action and gene polymorphisms (CYP P450, TPH etc). The literature data on pharmacogenetics are analyzed based on pharmacokinetcs and pharmacodynamics of andidepressants as well as in the aspect of identification of probable predictors for treatment response.

Keywords:

depression
therapy
pharmacogenetics
pharmacokinetcs
pharmacodynamics

Authors:

Ivanets N.N.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Tikhonova Iu.G.

Kafedra psikhiatrii i narkologii GBOU VPO "Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova" Minzdrava RF;
Nauchno-obrazovatel'nyĭ klinicheskiĭ tsentr "Psikhicheskoe zdorov'e", Moskva

Kinkul'kina M.A.

Kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Avdeeva T.I.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.